Vexev
PrivateLast Round
Seed
Aug 6, 2026
Total Funding Raised
$12M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vexev operates in Healthcare & Life Sciences and is based in Sydney, New South Wales. Its latest recorded funding round was a Seed round in August 2026.
Vexev is a healthcare technology company that is developing a medical imaging technology designed to measure and track blood flow patterns in patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Industrial Robotics, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vexev Comparables
Compare Vexev with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sonavex | 88% | |
| PatenSee | 81% | |
| Moonrise Medical | 78% |
For institutional investors. Book with your work email.
Vexev Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 6, 2026 | ||||
| Seed | Nov 14, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vexev Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startmate | Seed |
| Bioshore Capital Partners | Seed |
| Horizon | Seed |
| Propeller | Seed |
| Neotribe Ventures | Seed |
| Alumni Ventures | Seed |
| Blackbird Ventures | Seed, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 6, 2026
$6M round with participation from Blackbird Ventures.
- Aug 5, 2023
Grew 16% QoQ, from 19 to 22 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 6, 2026
On Aug 6th '26 in Australia, Vexev is developing VxWave, its robotic tomographic ultrasound platform, to improve access to standardized vascular imaging, with upper-limb imaging and dialysis vascular access as its initial application following a multi-site study with U.S. Renal Care.
- receives_financingAug 6, 2026
Vexev raises $6M in new funding in Australia on Aug 6th '26 to accelerate FDA 510(k) clearance and U.S. commercialization of VxWave, its robotic tomographic ultrasound platform.
For institutional investors. Book with your work email.
Vexev Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vexev's valuation, stock price, and market status.
Is Vexev a public or private company?
Vexev is a private company.
What is the current stock price of Vexev?
Vexev is a private company, so its shares have no public market price. Caplight tracks Vexev's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vexev worth (valuation)?
Valuation information for Vexev is not publicly available.
Can I buy Vexev stock?
Vexev shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vexev's last funding round?
Vexev's most recent funding round was Seed on August 6, 2026.
Who are the main investors in Vexev?
Key investors in Vexev include Neotribe Ventures, Blackbird Ventures.
Will Vexev IPO soon?
No public IPO plans have been announced for Vexev.
How can I track Vexev secondary market activity?
Caplight tracks bids, offers, and trades in Vexev's shares on secondary markets.